carotid
bodi
highli
vascularis
network
chemoreceptor
cell
locat
bifurc
intern
extern
carotid
arteri
common
carotid
arteri
carotid
bodi
chemoreceptor
call
glomu
type
catecholsecret
cell
releas
dopamin
respons
rapid
chang
arteri
oxygen
pressur
po
carbon
dioxid
pressur
pco
ph
thu
increas
carotid
bodi
sinu
nerv
activ
provok
centrallymedi
cardiopulmonari
respons
gonzalez
et
al
context
carotid
bodi
critic
physiolog
respons
acut
chronic
intermitt
hypoxia
hypoxia
activ
ra
might
associ
chronic
cardiopulmonari
diseas
sleep
apnea
great
interest
context
emerg
evid
exist
local
carotid
angiotensingener
system
upregul
chronic
hypoxia
alter
carotid
chemoreceptor
sensit
mention
newli
discov
function
intrins
angiotensingener
system
identifi
mani
tissu
organ
particular
physiolog
pathophysiolog
interest
system
recent
propos
exist
carotid
bodi
key
ra
compon
includ
angiotensinogen
ace
receptor
well
receptor
tabl
local
express
absenc
renin
thu
suggest
exist
reninindepend
biosynthet
pathway
angiotensin
ii
carotid
bodi
local
ra
carotid
bodi
play
key
role
modul
carotid
bodi
respons
hypoxia
angiotensin
ii
increas
carotid
bodi
effer
activ
presum
via
activ
receptor
allen
meanwhil
chronic
hypoxia
upregul
sever
key
ra
compon
carotid
bodi
includ
timecours
depend
ace
activ
lam
leung
lam
et
al
specif
receptor
express
glomu
cell
enhanc
consist
increas
transcript
translat
receptor
leung
et
al
chronic
hypoxia
thu
enhanc
receptormedi
effer
activ
leung
et
al
addit
receptor
activ
increas
intracellular
calcium
level
dissoci
glomu
cell
effect
enhanc
threefold
chronic
hypoxaemia
fung
et
al
interestingli
postnat
hypoxemia
associ
increas
sensit
peripher
chemoreceptor
respons
angiotensin
ii
condit
upregul
receptormedi
intracellular
calcium
activ
downregul
receptor
chemoreceptor
data
may
import
adapt
carotid
bodi
function
hypox
ventilatori
respons
electrolyt
water
balanc
perinat
postnat
hypoxia
fung
et
al
highaffin
bind
site
angiotensin
iv
known
receptor
also
call
insulinregul
membran
aminopeptidas
irap
found
local
express
variou
tissu
organ
albiston
et
al
discuss
chapter
angiotensin
iv
pentapeptid
contain
peptid
fragment
angiotensin
ii
metabolit
biolog
activ
peptid
ra
exert
action
via
mediat
receptor
interestingli
receptor
express
local
rat
carotid
bodi
importantli
play
promin
role
follow
upregul
chronic
hypoxia
fung
et
al
observ
consist
fact
express
function
local
ra
compon
notabl
receptor
ace
carotid
bodi
upregul
chronic
hypoxia
leung
et
al
lam
leung
lam
et
al
addit
activ
receptor
increas
local
product
angiotensin
ii
carotid
bodi
turn
elev
angiotensin
iv
thu
activ
intracellular
signal
cascad
lead
increas
intracellular
calcium
concentr
plausibl
specul
activ
receptor
carotid
bodi
may
serv
addit
pathway
enhanc
angiotensin
ii
action
activ
chemoreflex
physiolog
respons
chronic
hypoxia
fung
et
al
taken
togeth
avail
data
suggest
chronic
hypoxia
major
factor
increas
major
ra
compon
express
function
carotid
chemoreceptor
like
chang
cardiopulmonari
function
thu
excitatori
action
angiotensin
ii
glomu
cell
may
increas
chemosensit
carotid
bodi
may
counteract
blunt
effect
chronic
hypoxia
notwithstand
involv
receptormedi
carotid
bodi
function
detail
molecular
cellular
mechan
underli
modul
receptor
requir
extens
studi
recent
report
use
anim
model
congest
heart
failur
chf
role
local
glomu
angiotensin
iiat
receptor
signal
increas
sensit
kv
channel
hypoxia
shown
li
schultz
studi
high
concentr
angiotensin
ii
nm
directli
inhibit
kv
current
k
chang
kv
channel
protein
express
may
contribut
suppress
k
enhanc
sensit
k
hypoxia
chf
state
find
two
signific
implic
term
clinic
set
angiotensin
ii
enhanc
oxygen
sensit
kv
channel
via
receptor
cellular
angiotensin
leung
et
al
iiat
receptor
pathway
function
carotid
glomu
cell
chf
normal
anim
spite
solid
evid
precis
mechan
chf
upregul
angiotensin
iiat
receptor
function
carotid
bodi
yet
resolv
regard
chronic
impair
cardiac
output
result
chf
might
suffici
render
prolong
depriv
oxygen
deliveri
carotid
glomu
cell
state
akin
chronic
hypoxia
thu
lead
activ
cellular
ra
pathway
data
suggest
angiotensin
ii
may
paracrin
andor
autocrin
role
modul
enhanc
carotid
chemoreceptor
sensit
chronic
hypoxia
character
chf
leung
taken
togeth
aforement
find
suggest
chronic
hypoxia
major
factor
increas
major
ra
compon
express
carotid
bodi
activ
carotid
chemoreceptor
like
accompani
chang
cardiopulmonari
function
thu
excitatori
action
angiotensin
ii
action
via
receptor
glomu
cell
may
increas
chemosensit
carotid
bodi
counteract
blunt
effect
chronic
hypoxia
notwithstand
evid
function
angiotensingener
system
carotid
bodi
detail
molecular
cellular
mechan
underli
modul
requir
extens
investig
potenti
interact
circul
local
rasmedi
effect
carotid
bodi
regul
cardiopulmonari
function
normoxia
hypoxia
briefli
summar
fig
liver
metabol
activ
highli
aerob
organ
receiv
approxim
total
blood
flow
extract
oxygen
use
human
bodi
hardikar
suchi
liver
function
includ
limit
filtrat
storag
blood
metabol
carbohydr
protein
fat
hormon
foreign
chemic
format
bile
storag
vitamin
iron
format
coagul
factor
synthesi
hormon
precursor
angiotensinogen
excret
degrad
hormon
drug
toxin
exocrin
bile
secret
liver
compos
mainli
hepatocyt
liver
cell
repres
total
cell
popul
addit
hepat
cell
venou
sinusoid
line
three
type
cell
name
typic
endotheli
cell
larg
kupffer
cell
hepat
stellat
cell
kupffer
cell
type
macrophag
capabl
phagocyt
bacteria
foreign
matter
hepat
sinu
blood
alison
hepat
stellat
cell
repres
small
versatil
popul
cell
type
liver
major
function
rest
quiescent
hepat
cell
store
vitamin
whilst
activ
variou
stimuli
eg
injur
hepatocyt
activ
kupffer
cell
inflammatori
cytokin
reactiv
oxygen
speci
hepat
stellat
cell
acquir
myofibroblastlik
phenotyp
play
key
role
pathogenesi
liver
fibrosi
includ
collagen
deposit
abnorm
extracellular
matrix
remodel
atzori
et
al
angiotensinogen
best
known
synthes
liver
obligatori
compon
circul
local
ra
discuss
previou
section
system
local
rass
regul
liver
function
liver
diseas
role
particularli
true
local
hepat
ra
remain
larg
ambigu
liver
regard
recent
find
demonstr
express
sever
ra
compon
liver
ra
compon
includ
renin
ace
particular
two
receptor
subtyp
express
kupffer
cell
precursor
angiotensinogen
mandatori
compon
local
generatingangiotensin
system
howev
present
kupffer
cell
renin
ace
present
receptor
appear
exist
kupffer
cell
tabl
data
lend
support
exist
angiotensingener
system
liver
potenti
role
angiotensin
ii
hepat
kupffer
cell
interestingli
observ
suggest
angiotensin
ii
could
upregul
express
fibronectin
local
hepat
ra
act
via
receptor
locat
kupffer
cell
may
play
role
regul
fibrogen
action
use
dgalactosamineinduc
rat
model
liver
failur
receptor
blockad
demonstr
prevent
progress
acut
liver
injuri
evidenc
improv
surviv
reduct
liver
enzym
hepat
histopatholog
reduct
fibrogen
tissuespecif
inhibitor
metalloproteinsas
protein
chan
et
al
find
indic
hepat
receptor
may
mediat
liver
inflammatori
respons
liver
injuri
hand
ra
also
known
play
import
role
chronic
liver
diseas
includ
liver
cirrhosi
nonalcohol
steatohepat
nash
latter
frequent
caus
chronic
liver
impair
lubel
et
al
fact
ra
close
involv
liver
fibrosi
activ
hepat
stellat
cell
mediat
fibrogen
action
overexpress
profibrogen
factor
liver
anim
model
nash
shown
inhibit
receptor
attenu
aspart
aminotransferas
level
activ
hepat
stellat
cell
oxid
stress
express
transform
growth
express
collagen
gene
liver
fibrosi
hiros
et
al
addit
activ
receptor
sever
ra
compon
also
upregul
experiment
model
liver
fibrosi
includ
angiotensin
herath
et
al
inde
express
elev
injur
liver
human
rat
turn
regul
ra
activ
liver
fibrosi
paizi
et
al
rat
model
cirrhosi
bile
duct
ligat
recent
demonstr
angiotensin
highli
upregul
human
liver
diseas
antifibrot
action
support
notion
ma
receptor
axi
repres
potenti
target
antifibrot
therapi
observ
liver
cirrhosi
lubel
et
al
addit
administr
angiotensin
ii
increas
portal
pressur
experiment
human
cirrhosi
wherea
receptor
antagon
abrog
angiotensin
ii
effect
data
suggest
angiotensin
ii
may
involv
pathogenesi
portal
hypertens
cirrhosi
rockey
weisig
schneider
et
al
angiotensin
ii
also
shown
exert
contract
action
postsinusoid
venul
arroyo
et
al
local
receptor
hepat
stellat
cell
give
new
insight
direct
ra
research
respect
regul
liver
fibrosi
batal
et
al
recent
studi
also
shown
angiotensin
ii
induc
contract
prolifer
hepat
stellat
cell
via
receptor
taken
togeth
data
indic
angiotensin
ii
play
pivot
role
develop
liver
fibrosi
activ
hepat
stellat
cell
yoshiji
et
al
hand
kupffer
cell
known
get
activ
involv
fibrot
process
liver
casini
inde
kupffer
cell
constitut
sessil
macrophag
reticuloendotheli
system
major
sourc
cytokin
poli
cytokin
believ
activ
hepat
stellat
cell
induc
prolifer
differenti
stellat
cell
stimul
product
extracellular
matrix
compon
hepat
stellat
cell
fibronectin
despit
converg
evid
potenti
role
ra
clinic
relev
liver
diseas
yet
determin
uncertainti
particularli
true
local
hepat
ra
remain
larg
ambigu
investig
mention
earli
begin
section
liver
vital
organ
contain
sever
cell
type
name
hepatocyt
stellat
kupffer
cell
central
role
glucos
metabol
key
target
insulin
action
unsurpris
defect
liver
cell
function
increas
risk
type
diabet
mellitu
meanwhil
vitamin
known
best
calcium
bone
homeostasi
hypovitaminosi
vitamin
defici
also
increas
insulin
resist
impair
insulin
secret
associ
predict
metabol
syndrom
compon
also
nonalcohol
fatti
diseas
fibrosi
liver
nafld
recognis
part
metabol
syndrom
keep
hypovitaminosi
link
enhanc
risk
nafld
targher
et
al
hepat
fibrosi
cirrhosi
develop
patient
harrison
hypovitaminosi
associ
increas
risk
compon
metabol
syndrom
central
obes
glycemia
blood
pressur
advers
lipid
profil
insulin
resist
cardiovascular
diseas
see
review
boucher
mechan
explain
vitamin
effect
insulin
sensit
fulli
elucid
islet
cell
function
may
includ
increas
intracellular
ionis
calcium
modul
mani
gene
vitamin
receptor
respons
element
promot
region
wang
et
al
nafld
increas
hepat
insulin
resist
independ
gener
obes
human
vitamin
inhibit
adipogenesi
via
vitamin
receptor
vdr
mediat
inhibit
activ
woo
et
al
vitamin
activ
liver
holli
local
fulli
function
vdr
kupffer
stellat
endotheli
cell
well
hepatocyt
gascon
barr
et
al
thu
vitamin
could
expect
exert
direct
effect
hepat
insulin
signal
pathway
gene
concurr
sever
clinic
studi
report
invers
relationship
circul
concentr
activ
vitamin
blood
pressur
patient
highrenin
activ
hypertens
lind
et
al
burgess
et
al
vdrnull
mice
shown
defect
increas
renin
express
consist
suggest
vitamin
neg
regul
ra
li
et
al
potenti
mechan
effect
subsequ
demonstr
show
angiotensin
ii
feedback
suppress
renin
express
differ
vdrnull
mice
compar
wild
type
mice
kong
li
light
background
find
plausibl
suggest
vitamin
via
direct
action
modul
ra
activ
could
exert
effect
hepat
insulin
sensit
nafld
metabol
syndrom
first
step
test
hypothesi
first
examin
local
express
regul
major
ra
compon
anim
model
obesityinduc
dbdb
diabet
mous
protein
level
receptor
ace
renin
obes
diabet
mice
significantli
upregul
receptor
downregul
compar
respect
control
liver
evidenc
western
blot
analysi
fig
mean
doubl
immunostain
receptor
specif
local
hepat
stellat
cell
hepatocyt
kupffer
cell
immunoreact
much
intens
liver
obes
diabet
mice
compar
respect
control
liver
fig
preliminari
data
avail
address
hypothesi
vitamin
specif
reduc
hepat
insulin
resist
modul
local
hepat
ra
address
issu
studi
effect
hormon
vitamin
hepat
ra
activ
hepat
insulin
receptor
postinsulin
receptor
signal
pathway
relev
insulin
sensit
vitro
vivo
also
determin
whether
human
hepat
insulin
sensit
specif
increas
adequ
supplement
hypovitaminosi
whether
associ
circul
ra
activ
reduct
insulin
resist
contribut
cardiovascular
diseas
metabol
syndrom
increasingli
common
worldwid
problem
present
huge
demand
healthcar
resourc
thu
find
may
provid
novel
approach
prevent
manag
nafld
well
metabol
syndrom
sequela
two
primari
physiolog
role
intestin
digest
food
absorpt
electrolyt
nutrient
glucos
glucos
crucial
metabol
substrat
cell
type
achiev
glucos
uptak
differ
cell
type
bodi
two
categori
glucos
transport
one
secondari
activ
transport
ie
sglt
facilit
transport
ie
glut
tabl
absorpt
glucos
involv
entryandexit
mechan
mediat
two
separ
protein
carrier
locat
brush
border
membran
bbm
basolater
membran
blm
enterocyt
wright
et
al
mechan
energ
bbm
bound
atpdepend
na
pump
activ
glucos
transport
maintain
na
gradient
favour
entri
na
concomit
cotransport
glucos
galactos
enterocyt
sglt
protein
express
mani
tissu
particularli
epitheli
cell
small
intestin
wright
et
al
wright
et
al
found
kidney
pajor
et
al
kanai
et
al
second
carrier
locat
blm
facilit
glucos
expuls
cell
glut
famili
transport
consist
member
commonli
express
isoform
involv
glucos
uptak
renal
intestin
epithelia
kellett
et
al
enterocyt
bbm
highaffin
lowcapac
transport
allow
activ
glucos
uptak
intestin
lumen
glucos
uptak
turn
promot
insert
apic
membran
provid
addit
high
capac
pathway
glucos
transport
crucial
absorb
high
level
express
local
stellat
cell
reelin
marker
hepatocyt
albumin
marker
kupffer
cell
marker
liver
obes
diabet
dbdb
mice
control
lean
dbm
mice
immunoreact
immunolabel
specif
liver
cell
marker
stellat
cell
reelin
hepatocyt
albumin
b
kupffer
cell
c
immunoreact
stain
red
reelin
albumin
immunoreact
stain
green
see
arrow
overlay
immunofluoresc
label
dbdb
liver
show
intens
immunostain
observ
stellat
cell
kupffer
cell
hepatocyt
merg
imag
compar
respect
control
liver
dapi
use
marker
cell
nuclei
blue
origin
magnif
interpret
refer
colour
figur
legend
pleas
refer
onlin
version
lumin
glucos
gener
peak
carbohydr
digest
activ
inde
transport
capabl
bbm
three
time
greater
kellett
kellett
brotlaroch
glucos
exit
enterocyt
mainli
kidney
renal
uptak
glucos
tissu
mainli
red
blood
cell
brain
basal
uptak
glucos
transport
across
bloodbrain
barrier
betacel
pancrea
liver
kidney
gut
regul
insulin
releas
aspect
glucos
homeostasi
brain
kidney
placenta
tissu
uptak
neuron
tissu
muscl
adipos
tissu
insulinmedi
uptak
glucos
gut
kidney
intestin
absorpt
fructos
via
simpl
diffus
across
blm
apart
glucos
galactos
third
form
absorb
monosaccharid
fructos
transport
anoth
facilit
glucos
transport
summari
fig
illustr
glucos
well
galactos
uptak
enterocyt
normal
condit
notwithstand
involv
wellestablish
secondari
activ
transport
glucos
uptak
precis
mechan
mediat
novel
regul
consequ
affect
glucos
uptak
bbm
enterocyt
yet
fulli
elucid
divers
factor
well
evergrow
candid
govern
glucos
transport
locat
enterocyt
intestin
glucos
uptak
regard
rate
intestin
glucos
transport
subject
regul
hormon
lumin
peptid
stimulatori
inhibitori
effect
stimulatori
regul
includ
insulin
pennington
et
al
pancreat
glucagon
debnam
sharp
gastric
inhibitori
peptid
cheeseman
tsang
glucagonlik
cheeseman
cholecystokinin
hirsh
cheeseman
well
leptin
ducroc
et
al
angiotensin
ii
leung
latter
two
inhibitori
peptid
far
angiotensin
ii
concern
sever
local
rass
function
correl
identifi
gastrointestin
system
includ
salivari
gland
stomach
intestin
colon
liver
pancrea
paul
et
al
leung
local
ra
compon
ace
renin
detect
small
intestin
mucosa
erickson
et
al
seo
et
al
propos
mucos
ace
may
function
brush
border
membran
peptidas
yoshioka
et
al
despit
find
ace
present
intestin
bbm
inform
avail
transport
action
local
produc
angiotensin
ii
membran
steven
et
al
naim
vascular
infus
low
concentr
angiotensin
ii
shown
stimul
intestin
fluid
transport
via
receptor
howev
higher
level
angiotensin
ii
inhibit
fluid
transport
via
receptordepend
process
jin
et
al
studi
use
proxim
tubul
cell
glucos
uptak
process
similar
enterocyt
impli
local
secret
angiotensin
ii
affect
sugar
transport
exampl
angiotensin
ii
inhibit
uptak
glucos
analogu
llcpk
cell
reduc
express
sodiumdepend
glucos
transport
apic
membran
kawano
et
al
despit
find
direct
involv
local
ra
control
intestin
glucos
transport
howev
yet
conclus
demonstr
literatur
background
recent
found
compel
evid
exist
enterocyt
ra
gener
angiotensin
ii
local
lead
rapid
inhibit
intestin
glucos
uptak
studi
express
key
ra
compon
gene
protein
level
examin
jejun
ileal
enterocyt
mucos
uptak
glucos
evert
intestin
sleev
addit
angiotensin
ii
mucos
buffer
measur
presenc
absenc
losartan
receptor
antagonist
result
reveal
enterocyt
express
angiotensinogen
ace
receptor
receptor
angiotensinogen
protein
specif
local
bbm
express
angiotensinogen
mandatori
compon
local
ra
receptor
ace
greater
ileum
jejunum
addit
angiotensin
ii
mucos
buffer
inhibit
phlorizinsensit
jejun
glucos
uptak
rapid
dosedepend
manner
reduc
express
bbm
losartan
attenu
inhibitori
action
angiotensin
ii
glucos
uptak
despit
inhibitori
effect
glucos
uptak
angiotensin
ii
affect
jejun
uptak
lleucin
suggest
specif
action
intestin
glucos
absorpt
propos
mechan
rapid
inhibitori
effect
enterocytederiv
angiotensin
ii
involv
regul
intestin
glucos
transport
bbm
normal
condit
depict
fig
light
enterocyt
ra
find
proceed
explor
clinic
relev
enterocyt
ra
receptormedi
glucos
uptak
intestin
previou
studi
shown
streptozotocininduc
diabet
mellitu
promot
glucos
transport
across
rat
intestin
bbm
hopfer
debnam
et
al
burant
et
al
like
consequ
increas
bbm
express
debnam
et
al
debnam
et
al
kellett
brotlaroch
nevertheless
mechan
increas
transport
remain
larg
unexplor
previou
studi
shown
proxim
tubul
cell
abl
synthes
secret
angiotensin
ii
lumin
fluid
angiotensin
ii
might
involv
regul
sgltmediat
transport
cell
park
han
interestingli
exposur
proxim
tubul
cell
high
glucos
level
similar
seen
plasma
streptozotocindiabet
anim
reduc
angiotensin
ii
bind
cell
park
et
al
background
hypothes
express
ra
compon
enterocyt
bbm
would
subject
regul
diabet
mellitu
thu
affect
intestin
glucos
uptak
wong
et
al
preliminari
result
show
streptozotocininduc
diabet
week
durat
suffici
caus
increas
blood
glucos
level
reduc
mrna
protein
express
receptor
reduc
ace
level
isol
jejun
enterocyt
angiotensinogen
express
howev
stimul
diabet
whilst
renin
detect
either
control
diabet
enterocyt
consid
data
thu
plausibl
specul
local
ra
absenc
renin
ie
reninindepend
angiotensingener
system
exist
involv
angiotensin
ii
product
intestin
hand
streptozotocininduc
diabet
stimul
glucos
uptak
increas
express
protein
purifi
bbm
respect
immunocytochemistri
result
confirm
increas
bbm
express
diabet
condit
probabl
due
rapid
transloc
traffick
blm
bbm
addit
angiotensin
ii
nonpeptid
analogu
mucos
buffer
decreas
glucos
uptak
diabet
jejunum
respect
accordingli
potenc
time
greater
angiotensin
ii
furthermor
inhibitori
action
angiotensin
ii
due
reduc
phlorizinsensit
rather
phloretinsensit
transport
abolish
receptor
antagonist
losartan
decreas
efficaci
angiotensin
ii
glucos
uptak
diabet
compar
note
previous
jejunum
normal
anim
like
due
alter
ra
express
diabet
enterocyt
togeth
disproportion
increas
express
bbm
sinc
rate
intestin
glucos
transport
affect
insulin
releas
thu
glycaem
control
human
work
rais
issu
whether
enterocyt
ra
may
therapeut
target
reduc
glucos
transport
hand
higher
potenc
compar
angiotensin
ii
term
affect
glucos
transport
make
possibl
nonpeptid
receptor
agonist
may
use
gutdirect
treatment
reduc
postprandi
hyperglycaemia
diabet
patient
wong
et
al
conclus
propos
mechan
releas
inhibitori
effect
enterocytederiv
angiotensin
ii
may
involv
regul
enhanc
traffick
intestin
glucos
transport
bbm
diabet
intestin
fig
angiotensin
convert
enzym
first
homologu
newli
identifi
member
ra
bindom
lazartigu
apart
cellular
receptor
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
ren
et
al
membranebound
monocarboxypeptidas
capabl
gener
angiotensin
angiotensin
cleav
termin
leucin
phenylalanin
residu
angiotensin
angiotensin
ii
respect
iwai
horiuchi
result
two
separ
pathway
respons
angiotensin
product
bindom
lazartigu
angiotensin
bioactiv
peptid
ra
shown
benefici
effect
renal
cardiovascular
diseas
possibl
via
mediat
counterregul
aceangiotensin
santo
et
al
gproteincoupl
receptor
ma
receptor
act
receptor
angiotensin
found
express
mani
tissu
brain
heart
kidney
liver
iwai
horiuchi
view
fact
propos
exist
ma
axi
potenti
role
intestin
glucos
uptak
thu
test
hypothesi
use
cell
model
sambuy
et
al
human
colon
carcinoma
cell
line
examin
express
regul
ma
receptor
axi
high
glucos
exposur
preliminari
data
show
compon
angiotensin
ma
receptor
express
cell
ma
receptor
protein
express
c
cglucos
uptak
respons
angiotensin
gene
express
upregul
signific
increas
ma
receptor
exposur
high
glucos
compar
normal
concentr
ie
mm
vs
mm
fig
b
interestingli
exogen
addit
angiotensin
appear
dose
depend
inhibit
glucos
uptak
cell
line
demonstr
cglucos
assay
fig
hand
gene
express
also
dosedepend
upregul
polar
cell
high
glucos
exposur
significantli
upregul
expos
mm
glucos
day
fig
taken
find
togeth
preliminari
data
indic
exist
function
ma
axi
cell
line
may
provid
altern
mechan
andor
intestin
glucos
uptak
normal
diabet
condit
